Cargando…

Reduced free-living activity levels in pulmonary arterial hypertension patients

We conducted a survey of pulmonary arterial hypertension (PAH) patients and healthy controls who use either a smartphone or wearable fitness device that tracks daily step count. We found that PAH patients have markedly reduced activity levels compared to controls, after controlling for confounders.

Detalles Bibliográficos
Autores principales:	Halliday, Stephen J., Shi, Huang, Brittain, Evan L., Hemnes, Anna R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432689/ https://www.ncbi.nlm.nih.gov/pubmed/30419794 http://dx.doi.org/10.1177/2045894018814182

Ejemplares similares

Identifying “super responders” in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2017)

An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record
por: Schuler, Kyle P., et al.
Publicado: (2022)

Hemodynamic Improvement of Pulmonary Arterial Hypertension After Bariatric Surgery: Potential Role for Metabolic Regulation
por: Pugh, Meredith E., et al.
Publicado: (2013)

Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2023)

Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2018)

Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre‐ and postcapillary pulmonary hypertension
por: Babu, Gautam, et al.
Publicado: (2023)

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms
por: Meegan, Jamie E., et al.
Publicado: (2023)

Glyoxylase-1 combats dicarbonyl stress and right ventricular dysfunction in rodent pulmonary arterial hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2022)

Racial differences in patients referred for right heart catheterization and risk of pulmonary hypertension
por: Yang, Bin Q., et al.
Publicado: (2018)

Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
por: Hemnes, Anna R., et al.
Publicado: (2017)

Sex hormone exposure and reproductive factors in pulmonary arterial hypertension: a case–control study
por: Badlam, Jessica B., et al.
Publicado: (2020)

Predictors of Diastolic-To-Wedge Gradient in Patients Evaluated for Pulmonary Hypertension
por: Brittain, Evan L., et al.
Publicado: (2013)

A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific
por: Talati, Megha, et al.
Publicado: (2023)

Lack of a Tricuspid Regurgitation Doppler Signal and Pulmonary Hypertension by Invasive Measurement
por: O'Leary, Jared M., et al.
Publicado: (2018)

Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension
por: Brittain, Evan L., et al.
Publicado: (2020)

Shuttling toward Improved Clinic-based Assessment of Exercise Capacity in Pulmonary Arterial Hypertension
por: Brittain, Evan L.
Publicado: (2021)

Authors’ reply: role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2020)

Evidence of pulmonary arterial hypertension in two patients with common variable immunodeficiency
por: Huston, Jessica, et al.
Publicado: (2020)

Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
por: Caccamo, Marco, et al.
Publicado: (2023)

The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension
por: Meoli, David F., et al.
Publicado: (2017)

CD44 and xCT: The Silver Bullet for Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension?
por: Agrawal, Vineet, et al.
Publicado: (2019)

Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes
por: O’Leary, Jared M., et al.
Publicado: (2017)

Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension
por: Hemnes, Anna, et al.
Publicado: (2020)

Approach to a patient with pulmonary hypertension
por: Inampudi, Chakradhari, et al.
Publicado: (2019)

Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge
por: Agrawal, Vineet, et al.
Publicado: (2019)

An evidence-based knowledgebase of pulmonary arterial hypertension to identify genes and pathways relevant to pathogenesis
por: Zhao, Min, et al.
Publicado: (2014)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
por: Chang, Kevin Y., et al.
Publicado: (2022)

Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
por: Bonner, Nicola, et al.
Publicado: (2013)

Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms
por: Mathai, Stephen C., et al.
Publicado: (2019)

Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension
por: Egnatchik, Robert A., et al.
Publicado: (2017)

Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension
por: Trammell, Aaron W., et al.
Publicado: (2017)

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
por: Peters, Eva L., et al.
Publicado: (2021)

Cortisol/cortisone levels and quality of life in individuals with pulmonary arterial hypertension
por: Tulloh, RMR, et al.
Publicado: (2020)

Echocardiographic Pulmonary Artery Systolic Pressure in the Coronary Artery Risk Development in Young Adults (CARDIA) Study: Associations With Race and Metabolic Dysregulation
por: Brittain, Evan L., et al.
Publicado: (2017)

Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension
por: Prins, Kurt W., et al.
Publicado: (2020)

Identity crisis in pulmonary arterial hypertension
por: Ruffenach, G., et al.
Publicado: (2017)

Systemic arterial properties in pulmonary hypertension
por: Goodman, Randi, et al.
Publicado: (2021)

Premorbid weight in pulmonary arterial hypertension
por: Oppegard, Laura J., et al.
Publicado: (2023)

Echocardiographic evaluation of diastolic function in the setting of pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5mu3u2d6uf4uatfpcqdmphfuts